Preoperative administration of denosumab is a feasible adjuvant option for the treatment of resectable giant cell tumor of bone in the spine: A multi-institutional study by the Japanese Musculoskeletal Oncology group.
第一作者:
Takeshi,Morii
第一单位:
Department of Orthopaedic Surgery, Kyorin University Faculty of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan. Electronic address: dr.t.morii@gmail.com.
作者:
医学主题词
人类(Humans);女(雌)性(Female);男(雄)性(Male);骨巨细胞瘤(Giant Cell Tumor of Bone);回顾性研究(Retrospective Studies);脊椎肿瘤(Spinal Neoplasms);中年人(Middle Aged);成年人(Adult);日本(Japan);骨密度保护剂(Bone Density Conservation Agents);手术前护理(Preoperative Care);治疗结果(Treatment Outcome);青年人(Young Adult);化学疗法, 辅助(Chemotherapy, Adjuvant);肿瘤复发, 局部(Neoplasm Recurrence, Local);可行性研究(Feasibility Studies);老年人(Aged)
DOI
10.1016/j.jos.2025.10.011
PMID
41260962
发布时间
2026-05-08
- 浏览0
Journal of orthopaedic science
724-730页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



